a clinical evaluation of clarithromycin ( te-031 , a-56268 ) , a newly synthesized macrolide antibiotic , was made for its efficacy and safety in 30 patients with ages ranging from 8 month-old to 12 year- 2 month-old with mycoplasmal and bacterial infections .
C0055856
clarithromycin
C0004623
bacterial infections